Costs of type 2 diabetes mellitus from payers’ perspective: a study from real-world evidence of district hospital in Vietnam (300,00 руб.)

Первый автор	Nguyen
Авторы	Nguyen T., Pham T.T., Nguyen M.Q.
Страниц	10

ID	738568
Аннотация	Objective. Estimate yearly treatment cost of type 2 diabetes mellitus (T2DM) from payers’ perspective and its influencing factors. Method. A cross-sectional descriptive study has been conducted based on real-world evidence from Thu Duc district hospital from January 2017 to April 2018. Cost of T2DM was estimated based on payers’ perspective and included direct medical, direct non-medical and indirect costs. Result: Analyzing the sample of 206 patients with men: women rate of 1: 2.81 and mean age of 61.76±9.74, it has been shown that the average costs of T2DM per patient was accounted for US $ 1,038.3 (95% CI 951.4–1,125.2) with high proportion for direct costs (93.7%) and drugs cost (68.4% of direct medical costs and 60.6% of total costs). Costs per patient with complication was accounted for US $ 1,677.2 (95% CI 1,541.3–1,813.1), which is higher than those without complications (US $ 306.3 (95% CI 295.7–316.9)). Patients with comorbidities incurred higher average cost than those without them (p<0.05). Patients with previous inpatient hospitalization for T2DM or longer number of years for treating T2DM incurred higher cost (p<0.05). Patients with more risk factors or high HbA1c level also incurred higher costs (p<0.05). Conclusion: The average cost of T2DM was reported an estimate of US $ 1,038.3; in which average cost for patients with complication was 5 times higher than those without complication. HbA1c level, comorbidities and complication were the first 3 factors influencing average cost of T2DM.

Costs of type 2 diabetes mellitus from payers’ perspective: a study from real-world evidence of district hospital in Vietnam / T.T. Nguyen [и др.] // Фармация .— 2020 .— №4 .— С. 49-58 .— URL: https://rucont.ru/efd/738568 (дата обращения: 24.04.2024)